Skip to main content

Why Jim Cramer Is 'Excited' About Johnson & Johnson

Publish date:
Video Rating:
Video Duration:

Johnson & Johnson  (JNJ)  reported earnings on Tuesday. 

Johnson & Johnson said adjusted earnings came in at $1.86 cents per share, down 1.1% from the same period last year but four cents ahead of the Street consensus forecast. Group revenues, Johnson & Johnson said, rose 8.3% to $22.5 billion, again beating estimates of a $21.67 billion tally.

"Our notable full year performance reflects the continued confidence from patients, physicians, customers and consumers in our life-enhancing products and medicines, particularly throughout the COVID-19 pandemic," said CEO Alex Gorsky.

The company added that it will be releasing an update on its COVID-19 vaccine Phase 3 study 'soon.'

Everything Jim Cramer Is Watching in the Market Tuesday

Latest Videos From TheStreet and Jim Cramer:

Related Videos